Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 82 (RPL23AP82)

Target: RPL23AP82
Molecular classification: Other (Pseudogene, Non-coding RNA)

Overview

RPL23AP82 (ribosomal protein L23a pseudogene 82) is a transcribed unprocessed pseudogene located on human chromosome 22 (sometimes cited as chromosome 12). It represents a non-functional copy of the ribosomal protein L23a gene and does not produce a functional protein. Like other ribosomal protein pseudogenes, it may have roles in genomic architecture or regulatory RNA processes, but no specific biological function, disease association, or drug interactions have been established to date for RPL23AP82 itself. Its main relevance is for gene and genome research, annotation, and may provide insight into pseudogene biology. There are over a hundred known ribosomal protein L23a pseudogenes, but the functions of these individual pseudogenes are mostly unknown, and RPL23AP82 is not recognized as a receptor, target, or biomarker.

Other names: MGC70863RPL23A_43_1761

Mechanism of action

None — There are no mechanistic drug actions for this pseudogene.

Biological functions

None established for this specific pseudogene; as a pseudogene, it is not known to encode a functional protein or have direct cellular functions. Pseudogenes collectively may regulate gene expression via non-coding RNA mechanisms (such as mRNA stability), but no function is assigned to RPL23AP82 itself.

Disease associations

None established or reported for this specific pseudogene. Some pseudogenes have been linked to disease (RNA regulation, cancer, etc.), but RPL23AP82 is not involved directly in any known pathology. No evidence found for direct disease association.

Safety considerations

None reported — There are no safety or therapeutic challenges associated with this pseudogene.

Interacting drugs

None — There are no drugs known to interact with this pseudogene.

Biomarkers

None — It is not used as a biomarker for patient selection or therapeutic monitoring.

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 82 (RPL23AP82).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 82 (RPL23AP82).

Explore the full profile